D5 and D50 Administration Guidelines

Fundamental Composition and Clinical Indications

The American Academy of Pediatrics recommends using D5 for maintenance fluid therapy and prevention of hypoglycemia during insulin infusions, not for acute hypoglycemia treatment, as it provides 0.05 grams per mL and has an osmolarity of approximately 252 mOsm/L 2
D50 is recommended for acute treatment of severe hypoglycemia in patients with altered mental status or inability to take oral glucose, with an initial dose of 10-20 grams (20-40 mL) administered intravenously, titrated based on initial blood glucose severity 3, 4, 6

The optimal dosing strategy for hypoglycemia involves administering 5-gram aliquots of D50 repeated every 1-2 minutes, with blood glucose rechecked at 15 minutes post-administration, aiming for a target glucose level >70 mg/dL (or >100 mg/dL in neurologic injury patients) while avoiding overcorrection 3, 4, 6

The administration of D50 is associated with a risk of cardiac complications, including cardiac arrest and hyperkalemia, particularly with rapid or repeated boluses 3, 4, 6
D50 must be given slowly through a small-bore needle into a large vein to minimize thrombosis risk, and concentrated solutions >10% requiring sustained infusion need central venous access 4, 6

D5 with 0.45% NaCl is hypotonic and can cause hyponatremia in acutely ill patients with SIAD-like states, and is insufficient for acute treatment of severe hypoglycemia 2, 6